Skip to main content

Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference.

Wedbush PacGrow Healthcare Conference
1x1 Investor Meetings: August 8-9, 2023
Location: Lotte Palace Hotel, New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com


Primary Logo

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  263.99
+8.91 (3.49%)
AAPL  271.06
-2.37 (-0.87%)
AMD  347.81
+42.48 (13.91%)
BAC  52.05
-0.42 (-0.80%)
GOOG  342.32
+4.57 (1.35%)
META  675.03
+15.88 (2.41%)
MSFT  424.62
+8.87 (2.13%)
NVDA  208.27
+8.63 (4.32%)
ORCL  173.28
-3.00 (-1.70%)
TSLA  376.30
+2.58 (0.69%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.